This website uses cookies and similar technologies to optimize and improve the experience on our website. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our
Privacy Policy.
Accept
Toggle navigation
EN
|
CN
ABOUT US
Mission
Our Values
Corporate Executive Team
Board of Directors
Strategic Advisors
ESG Report
OUR SCIENCE
Introduction
Our Areas Of Focus
Pipeline
Partners
Literature Archive
NEWS
Press Releases
Media Reports
INVESTOR RELATIONS
Fact Sheet
Corporate Governance
Listing Documents
Announcements and Circulars
Share Graph
Financial Calendar
Presentation & Webcast
Financial Reports
Email Alert
Analyst Coverage
IR Enquiries
Replacement Of Lost Share Certificates
CAREERS
CONTACT US
B
REAKTHROUGH
INNOVATION & INSIGHT
Investor Relations
繁體
|
CN
|
EN
Fact Sheet
Corporate Governance
Listing Documents
Announcements and Circulars
Share Graph
Financial Calendar
Presentation & Webcast
Financial Reports
Email Alert
Analyst Coverage
IR Enquiries
Replacement Of Lost Share Certificates
Webcasts
Date
Title
Aug 24, 2022
Brii Biosciences 2022 Interim Results Conference Call
Jul 8, 2022
Brii Biosciences COVID-19 Neutralizing Amubarvimab/Romlusevimab Commercial Launch
Jun 27, 2022
Brii Bio at H.C. Wainwright 1st Annual Mental Health Conference
Mar 23, 2022
Brii Biosciences Full Year 2021 Financial Results and Corporate Progress Update Conference Call
Dec 13, 2021
Business Update Call: HIV Ph 1 Study Status
Dec 12, 2021
Business Update Call: Combination Antibody Retains Neutralizing Activity Against Omicron Variant
Aug 27, 2021
Brii Biosciences 2021 Interim Results Conference Call
Presentations
Date
Title
Oct 1, 2022
Corporate Presentation
Jun 27, 2022
HCW Mental Health Conference Presentation
×
